Quality of life instrument administered to the patient that enables healthcare providers to assess the quality of life of patients with irregular heart rhythm atrial fibrillation.
- Allows healthcare provider to evaluate the effects of atrial fibrillation and treatments on a patient more reliably.
- Examines physical, emotional, psychological, and social functioning of patient and is sensitive to changes in patient quality of life.
- Can be used during treatment, clinical trials, and other professional organizations involved in the care of patients with atrial fibrillation.
Atrial fibrillation is the most common arrhythmia and accounts for a third of hospital admissions for cardiac rhythm disturbances. Patients with atrial fibrillation have impaired quality of life and can be improved with various treatment strategies. Current scales to determine and track quality of life of patients with atrial fibrillation assess only the frequency and severity of atrial fibrillation episodes. There are, however, no quality of life scales specifically designed for atrial fibrillation that assess the impact of atrial fibrillation and its treatments on physical, emotional, psychological, and social functioning.
Emory researchers have created a quality of life scale and questionnaire that enables healthcare providers to assess the quality of life of patients with irregular heart rhythm atrial fibrillation. The Emory Living with Atrial Fibrillation Quality of Life (ELWAF) Scale is composed of two parts. The first part assesses the effect of atrial fibrillation on patient functioning (physical, emotional, psychological, and social) and the second part assesses the effect of various treatments for atrial fibrillation on daily life. The scale is designed to be sensitive to changes in the patient’s perception of atrial fibrillation between treatments and could be used by healthcare providers and during clinical trials.
A version of the scale has been developed.